Metropolis Healthcare Ltd

METROPOLIS

Watchlist

AI Mode

‌

Market Cap

₹ 9,939 Cr

P/E

62.82

‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

OVERVALUED

Growth

SLUGGISH

Profitability

MODERATE MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Metropolis Healthcare Limited is a leading diagnostic company in India, providing a comprehensive range of clinical laboratory tests for disease detection and monitoring.

The company's growth is driven by both organic expansion and strategic acquisitions, with recent moves enhancing its footprint in Northern India, particularly in oncology and genomics diagnostics.

Metropolis reported a strong 23% year-over-year revenue growth, bolstered by strategic acquisitions and growth in specialty and preventive health segments, despite a lower incidence of seasonal illnesses.

The company's focus on technology and AI is evident, with significant efforts toward automation and personalized medicine, enhancing operational efficiency and customer experience.

Metropolis is committed to sustainability, targeting significant reductions in emissions intensity and water usage by 2030, highlighting its long-term focus on environmental responsibility.

Sector

Healthcare

Industry

Diagnostic Services

Market Cap

9,939 Cr

Volatility

Low Risk

P/E Ratio

62.8

Industry P/E

48.3

PEG Ratio

2.6

P/B Ratio

6.9

52W High

2,259.30

52W Low

1,383.70

Sales CAGR

10.23%

1.69%

12.83%

10Y

—

Profit CAGR

13.27%

-14.48%

2.18%

10Y

—

ROE

TTM

11.05%

11.82%

16.32%

10Y

—

ROCE

TTM

14.12%

14.66%

19.09%

10Y

—

Technicals

‌

Forecasts

No. of Analysts

24

1Y Price Target

2271.37 ▲ 19.04%

Q3 EPS Estimate

Q3 Revenue Estimate

Unlock Premium Features

Price, EPS and Revenue Projections

Strong SellSellHoldBuyStrong Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

updated on

Dec 03, 2025

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VIJAYA	984.75	10,162 Cr	66.66	11.75	0.20	17.53	18.98	10.93
METROPOLIS	1917.10	9,939 Cr	62.82	6.94	0.00	11.05	14.12	7.97
THYROCARE	434.90	6,880 Cr	53.83	12.88	1.62	23.91	34.14	18.61
VIMTALABS	611.90	2,719 Cr	44.73	7.93	0.16	14.59	19.04	13.94
KRSNAA	742.75	2,428 Cr	28.71	2.63	0.37	9.16	11.09	5.61
SURAKSHA	285.60	1,485 Cr	46.53	6.45	0.00	13.86	14.74	8.19
ONEGLOBAL	606.65	1,186 Cr	27.02	11.70	0.00	43.51	58.07	19.53

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	277	309	291	331	313	350	323	345	386	429
Expenses	214	234	226	251	235	260	251	283	296	321
Operating Profit	63	75	65	80	79	90	72	62	90	108
OPM %	22.71	24.25	22.28	24.16	25.15	25.70	22.31	18.04	23.25	25.22
Other Income	3.05	1.22	2.31	2.54	2.46	3.13	2.56	6.97	7.52	0.89
Interest	5.98	5.68	5.31	5.57	4.65	4.79	4.53	4.60	5.20	5.68
Depreciation	21	22	25	26	26	27	28	29	31	32
Profit Before Tax	39	48	37	51	51	61	42	36	61	71
Tax %	26.05	25.88	25.97	27.73	25.39	23.94	25.65	18.90	26.11	25.54
Net Profit	29	36	27	37	38	47	31	29	45	53
EPS in Rs	5.55	6.82	5.22	7.00	7.29	8.93	6.03	5.66	8.66	10.13

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	647	761	856	998	1,228	1,148	1,208	1,331	1,404
Expenses	471	561	624	712	886	860	925	1,028	1,090
Operating Profit	176	200	233	286	343	288	283	303	314
OPM %	27.22	26.32	27.19	28.66	27.91	25.11	23.40	22.76	22.36
Other Income	7.77	6.78	-16	12	34	15	9.12	15	20
Interest	1.21	0.53	8.34	7.78	20	27	23	19	19
Depreciation	19	20	39	46	63	89	94	109	114
Profit Before Tax	164	187	169	244	293	188	175	191	201
Tax %	31.67	33.74	24.41	24.96	26.82	23.52	26.47	23.76	24.06
Net Profit	112	124	128	183	215	143	128	146	153
EPS in Rs	—	24.01	24.55	35.29	41.16	27.47	24.59	27.90	30.47
Dividend Payout %	0.00	55.20	31.68	22.35	19.20	28.77	16.08	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	9.54	10	10	10	10	10	10	10
Reserves	405	409	513	696	876	978	1,086	1,321
Borrowings	0.57	18	67	112	379	266	197	204
Other Liabilities	115	116	162	186	266	247	262	332
Total Liabilities	530	553	752	1,004	1,530	1,502	1,555	1,867
Fixed Assets	207	213	296	343	1,059	1,121	1,177	1,447
CWIP	0.00	5.77	2.99	0.00	5.78	20	0.00	0.00
Investments	102	33	14	10	16	15	55	71
Other Assets	221	301	439	651	450	347	323	349
Total Assets	530	553	752	1,004	1,530	1,502	1,555	1,867

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	104	90	215	249	253	247	264	263
Cash from Investing Activity	1.10	35	-105	62	-735	47	-89	-200
Cash from Financing Activity	-87	-118	-55	-33	163	-292	-181	-87
Net Cash Flow	18	7.35	55	278	-319	1.56	-6.54	-24

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	49.76%	49.75%	49.75%	49.74%	49.74%	49.67%	49.62%	49.43%	49.40%	48.90%	48.89%	48.89%
FIIs	23.86%	25.67%	25.66%	24.29%	21.66%	18.90%	18.25%	18.56%	16.73%	15.29%	12.83%	12.52%
DIIs	13.30%	13.64%	14.89%	16.86%	20.73%	24.86%	27.43%	28.02%	30.00%	30.30%	32.40%	33.10%
Public	13.08%	10.94%	9.70%	9.11%	7.87%	6.57%	4.70%	3.99%	3.87%	5.52%	5.88%	5.49%
Total Shareholders	91,452	84,269	89,692	86,249	79,878	68,283	58,108	51,852	48,572	49,293	50,015	47,846

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Dec 04, 2025	Core diagnostics (mauritius) ...	Bulk	Sell	1,905.11	55.72 Cr	2,92,457	0.56
Jun 02, 2025	Sushil shah family trust	Insider - Promoter	Acquisition	—	—	11,67,058	2.25
Jun 02, 2025	Sushil kanubhai shah	Insider - Promoter & Director	Disposal	—	—	11,67,058	2.25
Mar 28, 2025	Duru shah family trust	Insider - Promoter Group	Acquisition	—	—	7,65,659	1.47
Mar 28, 2025	Duru sushil shah	Insider - Promoter Group	Disposal	—	—	7,65,659	1.48
Aug 22, 2024	Sushil kanubhai shah	Insider - Promoter & Director	Disposal	2,100.33	1.58 Cr	7,500	0.01
Aug 22, 2024	Sushil kanubhai shah	Insider - Promoter & Director	Disposal	2,096.42	3.67 Cr	17,500	0.03
Aug 20, 2024	Sushil kanubhai shah	Insider - Promoter & Director	Disposal	2,059.27	8.24 Cr	40,000	0.07
Aug 20, 2024	Sushil kanubhai shah	Insider - Promoter & Director	Disposal	2,132.28	5.33 Cr	25,000	0.04
Jun 07, 2024	Sushil kanubhai shah	Insider - Promoter & Director	Disposal	2,005.37	3.01 Cr	15,000	0.02

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Investor Presentation

Q4 FY25

Investor Presentation

Q3 FY25

Investor Presentation

Q2 FY25

Investor Presentation

Q2 FY25

Investor Presentation

Q4 FY24

Investor Presentation

Q3 FY24

Showing 1 - 8 of 31

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VIJAYA	984.75	10,162 Cr	66.66	11.75	0.20	17.53	18.98	10.93
METROPOLIS	1917.10	9,939 Cr	62.82	6.94	0.00	11.05	14.12	7.97
THYROCARE	434.90	6,880 Cr	53.83	12.88	1.62	23.91	34.14	18.61
VIMTALABS	611.90	2,719 Cr	44.73	7.93	0.16	14.59	19.04	13.94
KRSNAA	742.75	2,428 Cr	28.71	2.63	0.37	9.16	11.09	5.61
SURAKSHA	285.60	1,485 Cr	46.53	6.45	0.00	13.86	14.74	8.19
ONEGLOBAL	606.65	1,186 Cr	27.02	11.70	0.00	43.51	58.07	19.53

Overview

Detailed Summary

Metropolis Healthcare Limited is a leading diagnostic company in India, providing a comprehensive range of clinical laboratory tests for disease detection and monitoring.

The company's growth is driven by both organic expansion and strategic acquisitions, with recent moves enhancing its footprint in Northern India, particularly in oncology and genomics diagnostics.

The company's focus on technology and AI is evident, with significant efforts toward automation and personalized medicine, enhancing operational efficiency and customer experience.

Metropolis is committed to sustainability, targeting significant reductions in emissions intensity and water usage by 2030, highlighting its long-term focus on environmental responsibility.

Sector

Healthcare

Industry

Diagnostic Services

Market Cap

9,939 Cr

Volatility

Low Risk

P/E Ratio

62.8

Industry P/E

48.3

PEG Ratio

2.6

P/B Ratio

6.9

52W High

2,259.30

52W Low

1,383.70

Sales CAGR

10.23%

1.69%

12.83%

10Y

—

Profit CAGR

13.27%

-14.48%

2.18%

10Y

—

ROE

TTM

11.05%

11.82%

16.32%

10Y

—

ROCE

TTM

14.12%

14.66%

19.09%

10Y

—